tiprankstipranks
Trending News
More News >
Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market

Provectus Pharmaceuticals (PVCT) Income Statement

Compare
79 Followers

Provectus Pharmaceuticals Income Statement

Last quarter (Q1 2025), Provectus Pharmaceuticals's total revenue was $278.63K, an increase of 17.04% from the same quarter last year. In Q1, Provectus Pharmaceuticals's net income was $-1.14M. See Provectus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 617.14K$ 557.71K$ 989.04K$ 0.00$ 0.00
Gross Profit
$ 609.98K$ -1.14M$ 925.26K$ -94.12K$ -315.00K
Operating Expenses
$ 5.15M$ 3.47M$ 3.39M$ 4.64M$ 4.65M
Depreciation and Amortization
$ 7.16K$ 8.92K$ 63.78K$ 94.12K$ 315.37K
EBITDA
$ -4.53M$ -2.89M$ -3.36M$ -4.62M$ -4.64M
Operating Income
$ -3.96M$ -2.90M$ -3.43M$ -4.67M$ -4.96M
Other Income/Expenses
$ -778.00K$ -201.00K$ -127.00K$ -867.00K$ -1.71M
Pretax Income
$ -4.73M$ -3.12M$ -3.56M$ -5.54M$ -6.68M
Net Income
$ -4.73M$ -3.10M$ -3.55M$ -5.54M$ -6.68M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ -0.02
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ -0.02
Weighted Average Shares Outstanding
419.81M 419.51M 419.47M 408.22M 393.25M
Weighted Average Shares Outstanding (Diluted)
419.81M 419.51M 419.47M 408.22M 393.25M
Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis